Molecular Diagnostics Quarterly Datastream, 2024

    Published: November 30, 2024 | Price: $10,500.00

    NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report.  All in any edition.  This is because this is a quarterly update to markets covered in these reports.   The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel spreadsheet...
    In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029

    Published: November 25, 2024 | Price: $5,000.00 – $10,500.00

    The U.S. IVD market is a cornerstone of global healthcare innovation—but it is also a market in transition In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029, the fifth edition in Kalorama’s ongoing series, offers unparalleled access to insights on the trends and technologies that will define the industry's future. This report is essential for: Identifying market gaps and opportunities for product innovation. Gaining a competitive edge with strategic insights into the U.S. diagnostic landscape. Making informed...
    Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029

    Published: November 19, 2024 | Price: $6,300.00 – $12,600.00

    Stay Ahead of the Curve with Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029: With the global demand for infectious disease IVD products projected to surge, understanding market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern.   Abstract As infectious diseases continue to pose significant global health challenges, diagnostic testing has emerged as a vital tool...
    IVD Test Procedure Volumes, 2024-2029

    Published: October 8, 2024 | Price: $6,300.00 – $12,600.00

    Act Now – Be Prepared for Tomorrow’s IVD Market Don’t miss your chance to leverage Kalorama Information’s expert insights. Equip your business with the knowledge to anticipate changes, optimize product development, and maximize your strategies in the dynamic IVD landscape. Ready to take action? Purchase the IVD Test Procedure Volumes, 2024-2029 report today and secure your competitive advantage in this billion-dollar industry.   Abstract Kalorama Information's IVD Test Procedure Volumes, 2024-2029 report provides a deep dive into the global trends...
    The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition

    Published: August 29, 2024 | Price: $8,750.00 – $17,500.00

    Kalorama Information's The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 17th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2024 to 2029, and essential insights needed to understand the IVD market in its entirety. With every significant test category covered in detail, it's like having ten market research reports in one comprehensive volume. Key Features: Extensive Coverage: Detailed estimates and...
    The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028

    Published: July 26, 2024 | Price: $5,000.00 – $10,500.00

    Kalorama Information’s latest report, The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028, is now available for purchase. This comprehensive study delves into the dynamic landscape of LDTs, exploring both the services market and the market for test products sold to clinical laboratories. The Worldwide Market for Laboratory-Developed Tests includes comprehensive analysis of the effects of the FDA's new "Medical Devices: Laboratory Developed Tests" rule, passed in April 2024, which subjects LDTs to significantly greater regulatory oversight. Inclusion Criteria for LDTs: 2023-2024: LDTs...
    The Worldwide Market for Clinical Laboratory Services, 9th Edition

    Published: June 26, 2024 | Price: $5,000.00 – $10,500.00

    Discover Comprehensive Insights with Kalorama’s Clinical Laboratory Services Report Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies poised to earn the most revenue and examines their strategies post-COVID-19 as the virus becomes endemic....
    Histology and Cytology IVD Market Update, 2024

    Published: May 21, 2024 | Price: $5,000.00 – $10,500.00

    Histology and Cytology IVD Market Update, 2024 provides an in-depth competitive analysis of the histology/cytology market from 2023 to 2028. The forecasted market analysis from 2023 to 2028 is based on demographic trends, new technological developments, innovative products, and global market expansion. This comprehensive review offers insights into the future direction of the histology and cytology IVD market, highlighting the potential for growth and advancements. Histology and cytology have long been essential components of pathological laboratories, offering critical insights into...
    The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition

    Published: April 23, 2024 | Price: $7,000.00 – $14,000.00

    NOW IN ELEVEN EDITIONS—The Worldwide Market for Point-of-Care (POC) Diagnostic Tests forecasts the POC market through 2028. Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in vitro diagnostics (IVD) industry. However, the point-of-care (POC) segment is seen as a key growth area. Point-of-care refers to tests that can provide meaningful results during a provider visit or in the patient's home. Over the past two decades, Kalorama Information has observed that POC tests present significant...
    The Market for Molecular Point-of-Care (mPOC), 2024

    Published: March 7, 2024 | Price: $5,000.00 – $10,500.00

    Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...
    The IVD Market in South Korea, 2024

    Published: February 26, 2024 | Price: $5,000.00 – $10,500.00

    The IVD Market in South Korea, 2024 offers a comprehensive overview of the in vitro diagnostics (IVD) market in South Korea and the factors shaping it. The report presents South Korea's IVD revenues for 2023 and forecasts for 2028, segmented into clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences. The report...
    The World Market for Veterinary Diagnostics, 7th Edition

    Published: January 22, 2024 | Price: $5,000.00 – $10,500.00

    Diagnostic testing plays a crucial role in animal healthcare, offering veterinarians a diverse range of tests for disease identification and monitoring. The efficacy of diagnostic testing relies on swift, reliable, and accurate methods, facilitating informed diagnoses. Despite various challenges, the veterinary diagnostics market has shown consistent growth and is forecasted to continue on this trajectory. This sector presents a rapidly expanding market opportunity for in vitro diagnostic (IVD) companies and others who can leverage the ongoing demand to ensure agricultural...
    The Worldwide Market for Liquid Biopsy, 6th Edition

    Published: December 29, 2023 | Price: $5,000.00 – $10,000.00

    Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated with traditional methods. Key applications of liquid biopsy testing in clinical oncology include: Early Detection and Diagnosis/Screening: Identifying cancer at an early stage. Alternative Testing...
    The World Market for Molecular Diagnostics, 12th Edition

    Published: December 19, 2023 | Price: $3,750.00 – $7,500.00

    Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the market remains ripe with opportunity, notably in the areas of infectious diseases, cancer, and transplant diagnostics. Global demand persists, with...
    Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028

    Published: November 29, 2023 | Price: $5,000.00 – $10,000.00

    In recent decades, the introduction of various new genetic technologies for research use and diagnostics has revolutionized many areas and opened new frontiers in healthcare.  For example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost.  While older, PCR continues to be innovated and remains a central tool in molecular diagnostics laboratories of all kinds, and in situ hybridization...